Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
shpmf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Shanghai Pharmaceuticals Holding Co., LtdYou SHPMF | $8.5B | N/A | — | — |
 Bangkok Dusit Medical Services Public Company Limited BDUUF | $9.5B | 18.66x | -12.4% | $1.00 |
 Eisai Co., Ltd. ESAIY | $6.6B | 34.14x | +60.3% | $36.26 |
 Eisai Co., Ltd. ESALF | $6.7B | 34.59x | +62.4% | $137.64 |
 Grifols, S.A. GIFOF | $8.7B | 12.83x | -39.7% | $0.58 |
 Kyowa Kirin Co., Ltd. KYKOF | $6.7B | 19.39x | -8.9% | $128.18 |
 Sinopharm Group Co. Ltd. SHTDF | $7.2B | 8.14x | -61.8% | $2.23 |
Industry Average 6 peers with valid PE | — | 21.29x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) measures how much investors pay for each dollar of the company's trailing earnings. SHPMF's current PE ratio of N/A is calculated by dividing its stock price of $1.46 by its TTM earnings per share of —.
Frequently asked questions
SHPMF pe ratio · 6 questionsSHPMF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.46 and TTM EPS of —. Data sourced from Financial Modeling Prep via SHPMF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Shanghai Pharmaceuticals Holding Co., Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09